| 1 |
刘宗超, 李哲轩, 张阳, 等. 2020全球癌症统计报告解读 [J/OL]. 肿瘤综合治疗电子杂志, 2021, 7(2): 1-14.
|
| 2 |
Shokoohi A, Berthelet E, Gill S, et al. Treatment for recurrent differentiated thyroid cancer: a canadian population based experience [J]. Cureus, 2020, 12(2): e7122.
|
| 3 |
Chen HC, Cheng SC. Functional roles of protein splicing factors [J]. Biosci Rep, 2012, 32(4): 345-359.
|
| 4 |
Guturi K, Sarkar M, Bhowmik A, et al. DEAD-box protein p68 is regulated by β-catenin/transcription factor 4 to maintain a positivefeedback loop in control of breast cancer progression [J]. Breast Cancer Res, 2014, 16(6): 496.
|
| 5 |
Sarkar M, Khare V, Guturi K, et al. The DEAD box protein p68:a crucial regulator of AKT/FOXO3a signaling axis in oncogenesis [J]. Oncogene, 2015, 34(47): 5843-5856.
|
| 6 |
石璐, 郭志义. DDX5在肿瘤中的作用机制 [J]. 健康之路, 2018, 175(9): 53-54.
|
| 7 |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016 [J].CA Cancer J Clin, 2016, 66(1): 7-30.
|
| 8 |
Pellegriti G, Frasca F, Regalbuto C. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors [J]. J Cancer Epidemiol, 2013, (2013): 965212.
|
| 9 |
Iggo RD, Jamieson DJ, MacNeill SA, et al. p68 RNA helicase: identification of a nucleolar form and cloning of related genes containing a conserved intron in yeasts [J]. Mol Cell Biol, 11(3): 1326-1333.
|
| 10 |
Bond AT, Mangus DA, He F, et al. Absence of Dbp2p alters both nonsense-mediated mRNA decay and rRNA processing [J]. Mol Cell Biol, 2001, 21: 7366-7379.
|
| 11 |
Budkevich TV, El'skaya AV, Nierhaus KH. Features of 80S mammalian ribosome and its subunits [J]. Nucleic Acids Res, 2008, 36(14): 4736-4744.
|
| 12 |
Sulić S, Panić L, Dikić I, et al. Deregulation of cell growth andmalignant transformation [J]. Croat Med J, 2005, 46(4): 622-638.
|
| 13 |
Kitamura A, Nishizuka M, Tominaga K, et al. Expression of p68 RNA helicase is closely related to the early stage of adipocyte differentiation of mouse 3 T3-L1 cells [J]. Biochem Biophys Res Commun, 2001, 287: 435-439.
|
| 14 |
Meola G, Jones K, Wei C, et al. Dysfunction of protein homeostasis in myotonic dystrophies [J]. Histol Histopathol, 2013, 28(9): 1089-1098.
|
| 15 |
Abdelhaleem M. Do human RNA helicases have a role in cancer? [J]. Biochim Biophys Acta, 2004 , 1704(1): 37-46.
|
| 16 |
Causevic M, Hislop RG, Kernohan NM, et al. Overexpression and poly-ubiquitylation of the DEAD-box RNA helicase p68 in colorectal tumours [J]. Oncogene, 2001, 20(53): 7734-7743.
|
| 17 |
Mazurek A, Luo W, Krasnitz A, et al. DDX5 regulates DNA replication and is required for cell proliferation in a subset of breast cancer cells [J]. Cancer Discov, 2012, 2(9): 812-825.
|
| 18 |
Wang Z, Luo Z, Zhou L, et al. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway [J]. Cancer Sci, 2015, 106(10): 1303-1312.
|
| 19 |
Clark EL, Coulson A, Dalgliesh C, et al. The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer [J]. Cancer Res 2008, 68: 7938-7946.
|
| 20 |
Wang SJ, Zhang C, You Y, et al. Overexpression of RNA helicase p68 protein in cutaneous squamous cell carcinoma [J]. Clin Exp Dermatol, 2012, 37: 882-888.
|
| 21 |
Lin S, Tian L, Shen H, et al. DDX5 is a positive regulator of oncogenic NOTCH1 signaling in T cell acute lymphoblastic leukemia [J]. Oncogene, 2013, 32(40): 4845-4853.
|
| 22 |
Ye X. Confluence analysis of multiple omics on platinum resistance of ovarian cancer [J]. Eur J Gynaecol Oncol, 2015, 36(5): 514-519.
|
| 23 |
Sun J, Wen X, Jin F, et al. Bioinformatics analyses of differentially expressed genes associated with bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma [J]. Onco Targets Ther, 2015, 8: 2681-2688.
|
| 24 |
Yu J, Liang QY, Wang J, et al. Zinc-finger protein 331, a novel putative tumor suppressor, suppresses growth and invasiveness of gastriccancer [J]. Oncogene, 2013, 32(3): 307-317.
|